SNHG11 :A New Budding Star in Tumors and Inflammatory Diseases
CONCLUSION: LncRNA SNHG11 can serve as an early diagnostic biomarker, therapeutic target, and prognostic indicator in various diseases, particularly tumors. SNHG11 plays a crucial role in the occurrence and development of tumors and inflammatory diseases through various mechanisms, which has significant implications for clinical diagnosis and treatment.PMID:37165588 | DOI:10.2174/1389557523666230509122402
Source: Mini Reviews in Medicinal Chemistry - Category: Chemistry Authors: Yinxin Wu Source Type: research
More News: Brain Tumor | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemistry | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Glioma | Hepatocellular Carcinoma | Ischemic Stroke | Liver Cancer | Lung Cancer | Myocarditis | Ovarian Cancer | Ovaries | Palliative | Pancreas | Pancreatic Cancer | Pancreatitis | Prostate Cancer | Stroke | Study